Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Product › Details

CRISPR gene editing technology

	Next higher product group	nucleic acid editing technology (DNA/RNA-editing technology)
	Status	2013-09-16 use/installation existent

Record changed: 2024-02-15

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for CRISPR gene editing technology

[1] Alia Therapeutics S.r.l.. (5/9/23). "Press Release: Alia Therapeutics Appoints Adel Nada as Independent Board Director". Milan....
[2] Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan....
[3] Alia Therapeutics S.r.l.. (4/17/23). "Press Release: Alia Therapeutics Secures €4.4 Million Seed Financing Extension Led by Sofinnova Partners". Milan....
[4] genOway S.A.. (1/7/20). "Press Release: genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models". Lyon....
[5] Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt....
[6] Cellectis S.A.. (2/13/18). "Press Release: Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells". New York, NY....
[7] Merck KGaA. (8/3/17). "Press Relase: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)